Oral rehydration salts and zinc for childhood diarrhoea in Bangladesh, 2019 and 2025: coverage, wealth inequality and reported source of care
Preprint
Abstract
Background: Diarrhoea remains a major cause of morbidity and mortality among children under five. WHO and UNICEF recommend oral rehydration salts (ORS) alongside 10 to 14 days of zinc supplementation. However, national progress in combined treatment coverage and its socioeconomic and care-related inequalities remains insufficiently understood in Bangladesh. We assessed combined coverage, wealth inequality and differences by reported source of care. Methods: In this repeated cross-sectional study, we analysed children under five with caregiver-reported diarrhoea in the 2019 (n=1,589) and 2025 (n=1,634) Multiple Indicator Cluster Surveys (MICS). We estimated combined coverage using design-based methods, wealth inequality using slope indices, and associations with source of care using pooled adjusted prevalence ratios (aPR). Demographic and Health Survey (DHS) estimates provided an external comparison. Results: Combined ORS and zinc coverage increased from 35.0% (95% CI 32.3 to 37.7) in 2019 to 42.9% (40.1 to 45.8) in 2025. This was an increase of 7.9 points (4.0 to 11.8). In 2025, ORS and zinc coverage were 75.8% and 51.9%, respectively. The 2025 estimate was similar to DHS 2022 (difference −0.4 points, −7.0 to 6.3), whereas MICS 2019 was below DHS 2017-18. Unadjusted wealth inequality persisted in 2025 (slope index 13.0 percentage points, 3.4 to 22.6). Adjustment for sociodemographic characteristics attenuated the pooled slope index from 11.8 to 6.5 points (−1.7 to 14.6). Coverage was lower with pharmacy-only than public care (aPR 0.59, 0.53 to 0.66) and with no care reported (0.14, 0.11 to 0.18). Children with no care reported accounted for 43.7% of children without combined treatment in 2025. Conclusions: Combined coverage increased within MICS, but fewer than half of children received both, and zinc remained the larger gap. Wealth inequality was partly shared with education and region. Children with no care reported formed the largest group without both treatments and need reaching outside facilities.Keywords
This publication has 41 references indexed in Scilit:
- Global burden of enteric infectious diseases, diarrhoeal diseases, and corresponding aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023The Lancet Infectious Diseases, 2026
- Temporal trends of diarrheal diseases and associated treatment responses among children aged under five: Insight from the multiple Indicator Cluster surveys from 2006 to 2019Pediatrics & Neonatology, 2024
- Global, regional, and national causes of under-5 mortality in 2000–19: an updated systematic analysis with implications for the Sustainable Development GoalsThe Lancet Child & Adolescent Health, 2022
- Mapping geographical inequalities in oral rehydration therapy coverage in low-income and middle-income countries, 2000–17The Lancet Global Health, 2020
- Mapping geographical inequalities in childhood diarrhoeal morbidity and mortality in low-income and middle-income countries, 2000–17: analysis for the Global Burden of Disease Study 2017The Lancet, 2020
- Oral zinc for treating diarrhoea in childrenCochrane Database of Systematic Reviews, 2016
- Fair society, healthy livesPublic Health, 2012
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesThe Lancet, 2007
- A Modified Poisson Regression Approach to Prospective Studies with Binary DataAmerican Journal of Epidemiology, 2004
- Measuring the magnitude of socio-economic inequalities in health: An overview of available measures illustrated with two examples from EuropeSocial Science & Medicine, 1997